Skip to main content

Moderna is the latest company to produce a promising RSV vaccine

The experimental respiratory syncytial virus vaccine prevented most infections in older adults in a Phase 3 clinical trial
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.